Biomerica
Quarterly Financials
| Values in thousands | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
|---|---|---|---|---|
Revenue | $1,119 | $1,636 | $1,807 | $1,116 |
Gross Profit | 19 | 437 | 289 | 20 |
EBITDA | -1,210 | -993 | -1,271 | -1,317 |
EBIT | -1,368 | -1,414 | ||
Net Income | -1,163 | -950 | -1,316 | -1,421 |
Net Change In Cash | 1,119 | 1,636 | 1,807 | 1,116 |
Free Cash Flow | -1,045 | -791 | -1,344 | -1,068 |
Cash | 3,058 | 2,372 | 2,820 | 4,170 |
Basic Shares | 19,186 | 17,121 | 16,821 | 16,821 |
Annual Financials
| Values in thousands | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
|---|---|---|---|---|
Revenue | $5,415 | $5,339 | $18,871 | $7,199 |
Gross Profit | 611 | 446 | 2,977 | 496 |
EBITDA | -5,993 | -6,738 | -3,939 | -7,057 |
EBIT | -6,367 | -7,089 | -4,533 | -7,433 |
Net Income | -5,978 | -7,140 | -4,531 | -6,469 |
Net Change In Cash | 5,415 | 5,339 | 18,871 | 7,199 |
Cost of Revenue | -4,441 | |||
Free Cash Flow | -5,476 | -5,552 | -650 | -5,547 |
Cash | 4,170 | 9,719 | 5,916 | 4,199 |
Basic Shares | 16,821 | 14,154 | 12,673 | 11,928 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-02-28 | -$0.06 |
2024-11-30 | -$0.05 |
2024-08-31 | -$0.07 |
2024-05-31 | -$0.08 |
